Report overview
The global Colloidal Bismuth Pectin Capsules market was valued at 50 million in 2024 and is projected to reach US$ 65.4 million by 2032, at a CAGR of 4.0% during the forecast period.
Colloidal bismuth pectin capsules are capsules made of colloidal bismuth pectin, which is a complex of pectin and bismuth with an indeterminate composition. This product is mainly used to treat gastric ulcer and gastritis.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
50mg/Pcs segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Colloidal Bismuth Pectin Capsules include China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Shanxi PUDE Pharmaceutical, Lionco Pharmaceutical Group, Guilin Hwasun Pharmaceutical, Renhe Pharmacy, Guangdong Pidi Pharmaceutical, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Colloidal Bismuth Pectin Capsules manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Colloidal Bismuth Pectin Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloidal Bismuth Pectin Capsules. This report contains market size and forecasts of Colloidal Bismuth Pectin Capsules in global, including the following market information:
Global Colloidal Bismuth Pectin Capsules market revenue, 2020-2025, 2026-2032, ($ millions)
Global Colloidal Bismuth Pectin Capsules market sales, 2020-2025, 2026-2032, (K Boxes)
Global top five Colloidal Bismuth Pectin Capsules companies in 2024 (%)
Total Market by Segment:
Global Colloidal Bismuth Pectin Capsules market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Boxes)
Global Colloidal Bismuth Pectin Capsules market segment percentages, by Type, 2024 (%)
50mg/Pcs
100mg/Pcs
Other
Global Colloidal Bismuth Pectin Capsules market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Boxes)
Global Colloidal Bismuth Pectin Capsules market segment percentages, by Application, 2024 (%)
Stomach Ulcer Treatment
Gastritis Treatment
Other
Global Colloidal Bismuth Pectin Capsules market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Boxes)
Global Colloidal Bismuth Pectin Capsules market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colloidal Bismuth Pectin Capsules revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Colloidal Bismuth Pectin Capsules revenues share in global market, 2024 (%)
Key companies Colloidal Bismuth Pectin Capsules sales in global market, 2020-2025 (estimated), (K Boxes)
Key companies Colloidal Bismuth Pectin Capsules sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Shanxi PUDE Pharmaceutical
Lionco Pharmaceutical Group
Guilin Hwasun Pharmaceutical
Renhe Pharmacy
Guangdong Pidi Pharmaceutical
Lionco Pharmaceutical Group
Gaoyou Zhaokang Pharmaceutical
Sichuan Emeishan Jinding Pharmaceutical
Charoen Pokphand Group
Guizhou Warmen Pharmaceutical
Sichuan Kelun Pharmaceutical
ZHEJIANG DND PHARMACEUTICAL
Luoyang Junshan Pharmaceutical
Anhui Yongshengtang Pharmaceutical Limited Liability Company
SHANGHAI XIANDAI HASEN (SHANGQIU) PHARMACEUTICAL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colloidal Bismuth Pectin Capsules, market overview.
Chapter 2: Global Colloidal Bismuth Pectin Capsules market size in revenue and volume.
Chapter 3: Detailed analysis of Colloidal Bismuth Pectin Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colloidal Bismuth Pectin Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Colloidal Bismuth Pectin Capsules capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
